Cefera T 1.25gm Injection
By Cefera T
Rx
10ml Injection in a Vial

Composition
Ceftriaxone(1000mg) + Tazobactum(250mg)

Manufacturer - Shreya Life Sciences Pvt Ltd
SHREYA HOUSE, 301/A, Pereira Hill Road, Andheri East, Mumbai - 400 099, India

Expires on or after
October, 2025

liver
When it comes to liver health, it is essential to approach the use of Cefera T 1.25gm Injection with caution, particularly in patients with severe liver disease. In such cases, it may be necessary to adjust the dosage of the injection, so consulting your doctor before use is crucial. However, for patients with mild to moderate liver disease, dose adjustment of Cefera T 1.25gm Injection is generally not recommended. It is always prudent to seek guidance from a healthcare professional to ensure the safe and appropriate use of this medication.

kidney
There is limited information regarding the use of Cefera T 1.25gm Injection in patients with kidney disease. Please consult your doctor for proper guidance.

alcohol
When taking Cefera T 1.25gm Injection, it is safe to consume alcohol as it does not result in any negative side effects. However, caution is advised during pregnancy.

driving
Cefera T 1.25gm Injection can reduce alertness and cause drowsiness, blurred vision, or dizziness. Avoid driving if you experience these effects.

pregnancy
Cefera T 1.25gm Injection is generally safe during pregnancy with minimal risk according to animal studies. Limited human studies are available so caution is advised.

breastfeeding
Cefera T 1.25gm Injection should be used with caution while breastfeeding. It is advised to suspend breastfeeding until the mother's treatment is finished and the drug is cleared from her body.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹260
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 11-Feb-2025